Launching the Iranian medicine "CinnoRA", in the presence of Minister of Health

25th of October was a great day for CinnaGen. Dr. Hassan Hashemi, Iranian minister of health, visited CinnaGen and launched our new product, CinnoRA.

CinnoRA is a kind of Monoclonal Antibodies which is used for treatment of different forms of autoimmune diseases like rheumatoid arthritis, polyarticular juvenile idiopathic arthritis in children who are at least 2 years old, psoriatic arthritis, ankylosing spondylitis, plaque psoriasis, and a chronic skin condition called hidradenitis suppurativa. CinnoRA is biosimilar form of Humira which is produced by abbvie. All qualitative, quantitative and clinical tests show the similarity of CinnoRA and Humira. Now patients who suffer from autoimmune diseases can use Iranian adalimumab which is more cost effective than other brands.

Oct2016 / Public Relations Department / CinnaGen